Back

Myocardial fibrosis predicts ventricular arrhythmias and sudden death after cardiac electronic device implantation

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Young Investigator Award - Clinical Device Treatment EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Abbasin Zegard

Aston University, Birmingham (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Comparison of the accuracy of contact force measurement in four commercially available force-sensing ablation catheters
Mr T. Kueffer (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Comparison of various late gadolinium enhancement magnetic resonance imaging methods to high-definition voltage and activation mapping for detection of atrial cardiomyopathy
Doctor M. Eichenlaub (Bad Krozingen, DE)
Abstract Slides Video
Presentation thumbnail
A positive toxicology screen is a rare finding in sports-related sudden cardiac deaths
Doctor C. Hansen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
More than half of all sudden cardiac deaths occur in persons without a history of cardiovascular disease: A study of 54,028 deaths in Denmark
Doctor T. Lynge (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Clinical
Video

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Presentation
When to consider device therapy in HFrEF - discussion
thumbnail
Congress Presentation
Case 2 - implantable cardioverter defibrillator, catheter ablation, or both for secondary prevention?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources